Showing 1 - 9 of 9
Patent expiration represents a turning point for the brand losing patent protection as bioequivalent generic versions of the drug quickly enter the market at reduced prices. In this paper, we study how physician characteristics and their prescribing decisions impact the competition among...
Persistent link: https://www.econbiz.de/10014025989
Persistent link: https://www.econbiz.de/10015138172
Persistent link: https://www.econbiz.de/10010353471
Persistent link: https://www.econbiz.de/10003793502
Persistent link: https://www.econbiz.de/10003737440
Persistent link: https://www.econbiz.de/10011490911
Persistent link: https://www.econbiz.de/10011317072
Persistent link: https://www.econbiz.de/10011596831
Motivated by the medical literature findings that physicians are inertial, we seek to understand (1) whether physicians exhibit structural persistence in drug choice (structural persistence occurs when the drug chosen for a patient depends structurally on the drug previously prescribed by the...
Persistent link: https://www.econbiz.de/10012756795